New shot aims to tackle two heart risks at once
NCT ID NCT07368608
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new medicine called BEBT-701, given as a shot under the skin, for people with mild to moderate high blood pressure and high LDL cholesterol. The goal is to see if it is safe and can help lower both blood pressure and cholesterol. About 340 adults aged 18 to 60 will take part. The study is in two parts: a single-dose phase and a multiple-dose phase.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Third Xiangya Hospital of Central South University
Changsha, Hunan, 410013, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a heart drug be a new key to controlling high blood pressure?
- A simple arm cuff may lower blood pressure without drugs
- AI tailors blood pressure drugs, outsmarting One-Size-Fits-All medicine
- Herbal capsule aims to tackle both high blood pressure and poor sleep
- New drug combo aims to tame stubborn high blood pressure
- New combo pill aims to tame stubborn high blood pressure